These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22627199)

  • 1. Soluble C-X-C chemokine ligand 16 levels are increased in gout patients.
    Gong Q; Wu F; Pan X; Yu J; Li Y; Lu T; Li X; Lin Z
    Clin Biochem; 2012 Nov; 45(16-17):1368-73. PubMed ID: 22627199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CXCL16 as a novel marker of renal injury in type 2 diabetes mellitus.
    Zhao L; Wu F; Jin L; Lu T; Yang L; Pan X; Shao C; Li X; Lin Z
    PLoS One; 2014; 9(1):e87786. PubMed ID: 24489966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma CXCL16 levels in patients with chronic kidney diseases.
    Lin Z; Gong Q; Zhou Z; Zhang W; Liao S; Liu Y; Yan X; Pan X; Lin S; Li X
    Eur J Clin Invest; 2011 Aug; 41(8):836-45. PubMed ID: 21299552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.
    Smith C; Halvorsen B; Otterdal K; Waehre T; Yndestad A; Fevang B; Sandberg WJ; Breland UM; Frøland SS; Oie E; Gullestad L; Damås JK; Aukrust P
    Cardiovasc Res; 2008 Jul; 79(1):195-203. PubMed ID: 18339644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine SR-PSOX/CXCL16 expression in peripheral blood of patients with acute coronary syndrome.
    Yang HL; Xu YY; DU LF; Liu CH; Zhao Q; Wei WJ; You Y; Quan ZH
    Chin Med J (Engl); 2008 Jan; 121(2):112-7. PubMed ID: 18272035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL16 haplotypes in patients with human carotid atherosclerosis: preliminary results.
    Zivković M; Djurić T; Stojković L; Jovanović I; Končar I; Davidović L; Veljković N; Alavantić D; Stanković A
    J Atheroscler Thromb; 2015; 22(1):10-20. PubMed ID: 25142184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
    Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
    Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gender-specific association of CXCL16 A181V gene polymorphism with susceptibility to multiple sclerosis, and its effects on PBMC mRNA and plasma soluble CXCL16 levels: preliminary findings.
    Stojković L; Stanković A; Djurić T; Dinčić E; Alavantić D; Zivković M
    J Neurol; 2014 Aug; 261(8):1544-51. PubMed ID: 24854635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
    Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
    Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating CXCL16 is not related to circulating oxLDL in patients with rheumatoid arthritis.
    van Lieshout AW; Popa C; Meyer-Wentrup F; Lemmers HL; Stalenhoef AF; Adema GJ; van Riel PL; van Tits LJ; Radstake TR
    Biochem Biophys Res Commun; 2007 Apr; 355(2):392-7. PubMed ID: 17300746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
    Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease.
    Sheikine Y; Bang CS; Nilsson L; Samnegård A; Hamsten A; Jonasson L; Eriksson P; Sirsjö A
    Atherosclerosis; 2006 Oct; 188(2):462-6. PubMed ID: 16378611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary UMOD excretion and chronic kidney disease in gout patients: cross-sectional case-control study.
    Wu CH; Lee CT; Lee CH; Cheng TT; Chang HW; Lin E; Chuang FR; Yang HP; Chen YC; Wu CY; Chen CJ
    Ren Fail; 2011; 33(2):164-8. PubMed ID: 21332338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    Clin Exp Immunol; 2007 Jul; 149(1):146-54. PubMed ID: 17459077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not all inflammatory markers are linked to kidney function: results from a population-based study.
    Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
    Aslanian AM; Charo IF
    Circulation; 2006 Aug; 114(6):583-90. PubMed ID: 16880330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum CXCL16 level is a marker for acute coronary syndromes.
    Sun Y; Chang Z; Zhang S
    Arch Med Res; 2008 Apr; 39(3):332-7. PubMed ID: 18279707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.